Large-scale testing (Phase 3)Ended earlyNCT04425629
What this trial is testing
Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19
Who this might be right for
COVID-19
Regeneron Pharmaceuticals 10,078